Mydlo MD / Godec Prostate Cancer

Science and Clinical Practice
2. Auflage 2015
ISBN: 978-0-12-800592-7
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, 672 Seiten

Prostate Cancer, Science and Clinical Practice, Second Edition, continues to be an important translational reference that bridges the gap between science and clinical medicine. It reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights the pitfalls where relevant, and examines the scientific developments that might result in future treatments. Key chapters from the previous edition have been updated, and a plethora of new chapters describe new concepts of prostate cancer biology and newly developed therapeutics. Each chapter has been written by internationally recognized specialists on prostate cancer epidemiology, genetic susceptibility, cancer metastases, prostate physiology, proteomics, new therapeutics, and clinical trials. - Presents a comprehensive, translational source for all aspects of prostate cancer in one reference work - Provides a common language for cancer researchers, oncologists, and urologists to discuss prostate tumors and how prostate cancer metastases affects other major organ systems - Offers insights to research clinicians, giving them a key understanding the molecular basis of prostate cancer - Offers insights to cancer researchers into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays

Autoren/Hrsg.

Mydlo MD, Facs

Godec, Ciril J.

Leseproben

List of Contributors
Philip H. Abbosh MD, PhD,     Department of Surgical Oncology, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA Firas Abdollah MD,     Vattikuti Urology Institute & VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA Mohan P. Achary PhD,     Department of Radiation Oncology and Radiology, Temple University School of Medicine, Philadelphia, PA, USA Shaheen Alanee MD, MPH,     Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA Peter C. Albertsen MD, MS,     Department of Surgery, University of Connecticut Health Center, Farmington, CT, USA Yousef Al-Shraideh MD,     Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA Gerald Andriole MD,     Division of Urological Surgery, Washington University in St. Louis, St. Louis, MO, USA Janet E. Baack Kukreja MD,     Department of Urology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA Richard K. Babayan MD,     Boston University School of Medicine, Boston, MA, USA Brock R. Baker BS,     Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA Christopher E. Bayne MD,     Department of Urology, The George Washington University, Washington, DC, USA Marijo Bilusic MD, PhD,     Department of Medical Oncology, Fox Chase Cancer Center/Temple University, Philadelphia, PA, USA Leonard P. Bokhorst MD,     Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands David B. Cahn DO, MBS,     Department of Urology, Einstein Healthcare Network, Philadelphia, PA, USA Daniel J. Canter MD,     Department of Urology, Fox Chase Cancer Center and Einstein Healthcare Network, Philadelphia, PA, USA David Y.T. Chen MD, FACS,     Department of Surgical Oncology, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA Ronald C. Chen MD, MPH,     Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA Juan Chipollini MD,     Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA Peter L. Choyke MD,     Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Matthew R. Cooperberg MD, MPH,     Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA Anthony Costello MD, FRACS, FRCSI,     Departments of Urology and Surgery, Royal Melbourne Hospital and University of Melbourne, Melbourne; Epworth Prostate Centre, Epworth Healthcare, Melbourne, Australia E. David Crawford MD,     University of Colorado Health Science Center, Aurora, CO, USA Curtiland Deville MD,     Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Sibley Memorial Hospital, Washington, DC, USA Essel Dulaimi MD,     Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA Danuta Dynda MD,     Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA John B. Eifler MD,     Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA Cesar E. Ercole MD,     Center for Urologic Oncology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA Daniel D. Eun MD,     Department of Urology, Temple University Hospital, Philadelphia, PA, USA Wouter Everaerts MD, PhD,     Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne; Department of Urology, Royal Melbourne Hospital, Parkville; and Epworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australia Izak Faiena MD,     Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA Michael A. Ferragamo MD, FACS,     Department of Urology, State University of New York, University Hospital, Stony Brook, NY, USA Chandra K. Flack MD,     Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA Tullika Garg MD, MPH,     Urology Department, Geisinger Health System, Danville, PA, USA Awet Gherezghihir MD,     Department of Surgery (Urology), The Penn State Milton S. Hershey Medical Center, Hershey, PA, USA Ciril J. Godec MD, PhD,     Department of Urology, SUNY Downstate University School of Medicine, Brooklyn, NY; Long Island College Hospital, Long Island, NY, USA Leonard G. Gomella MD,     Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA Richard E. Greenberg MD, FACS,     Division of Urologic Oncology, Fox Chase Cancer Center, and Temple University School of Medicine, Philadelphia, PA, USA Baruch Mayer Grob MD,     Urology Section, Hunter Holmes McGuire VA Medical Center, and Division of Urology, Virginia Commonwealth University Health System, Richmond, VA, USA Giorgio Guazzoni MD,     Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy Thomas J. Guzzo MD, MPH,     Division of Urology, The Hospital of the University of Pennsylvania, Philadelphia, PA, USA Ahmed Haddad MBChB, PhD,     Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA Maahum Haider MD,     Department of Urology, University of Washington School of Medicine, Seattle, WA, USA Andrew C. Harbin MD,     Department of Urology, Temple University Hospital, Philadelphia, PA, USA Eric M. Horwitz MD,     Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA Ahmed A. Hussein MD,     Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; Department of Urology, Cairo University, Oula, Giza, Egypt Timothy Ito MD,     Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA Thomas W. Jarrett MD,     Department of Urology, The George Washington University, Washington, DC, USA Lawrence C. Jenkins MD, MBA,     Sexual and Reproductive Medicine Program, Urology Service, Memorial...